Phase I Study to Assess the Combination of Afatinib with Trastuzumab in Patients with Advanced or Metastatic HER2-Positive Breast Cancer

Title
Phase I Study to Assess the Combination of Afatinib with Trastuzumab in Patients with Advanced or Metastatic HER2-Positive Breast Cancer
Authors
Keywords
-
Journal
CLINICAL CANCER RESEARCH
Volume 21, Issue 12, Pages 2737-2744
Publisher
American Association for Cancer Research (AACR)
Online
2014-11-05
DOI
10.1158/1078-0432.ccr-14-1812

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation